J Studios
Moody's (NYSE:MCO) capped off a remarkable 2024 with a strong fourth quarter, and an ambitious guide for 2025, coming above consensus estimates even at the low end.
You would expect the stock to at least hold well on
Moody's: Ratings Pull-Forward Worries Out, GDP And Economic Worries In
Summary
- Moody's had a slightly disappointing Q4, missing revenue estimates and underperforming S&P Global.
- Moody's did provide strong guidance for 2025, which was the biggest concern for investors heading into earnings.
- Despite that, the broad market selloff took Moody's down with it, with the stock now in a double-digit drawdown.
- I view Moody's as a 'Buy' due to its strong 2025 outlook, but prefer S&P Global and other 'Strong Buys' amid the market selloff.
I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on fundamentals, and hold them forever. I hope to publish articles covering such companies approximately 3 times per week, with extensive quarterly follow-ups and constant updates.I manage a concentrated portfolio targeted at avoiding losers and maximizing exposure to big winners. This means that often I'll rate great companies at a 'Hold' because their growth opportunity is below my threshold, or their downside risk is too high.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of SPGI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.